SARS-CoV-2 infection in patients with primary central nervous system lymphoma in the vaccination era

Leuk Lymphoma. 2023 Jan;64(1):221-224. doi: 10.1080/10428194.2022.2131420. Epub 2022 Nov 1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / prevention & control
  • Central Nervous System
  • Humans
  • Lymphoma* / diagnosis
  • Lymphoma* / therapy
  • SARS-CoV-2
  • Vaccination